Aims: To evaluate the specific role of the endocannabinoid/cannabinoid type-1 (CB 1 R) system in modulating mitochondrial dynamics in the metabolically active renal proximal tubular cells (RPTCs).
| INTRODUCTION
Mitochondrial morphology is highly dynamic over time, changing rapidly and significantly in response to cellular stress or to altered metabolic demand. 1 Mitochondria are shaped by ongoing fusion and fission events, and the lack of balance between these opposing processes is often detrimental to maintaining mitochondrial homeostasis. In fact, a breach in this balance has been implicated in the onset of many pathological conditions, such as neurodegenerative diseases and aging, as well as obesity and its related kidney injuries (reviewed in References 2 and 3 ).
The endocannabinoid (eCB) system plays an important role in energy balance and homeostasis. 4, 5 The main eCBs, Narachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG), evoke many cellular pathways by binding and activating the two G-protein-coupled receptors, cannabinoid type-1 (CB 1 R) and type-2 (CB 2 R). The eCB/CB 1 R system is highly overactive during obesity, 6, 7 and both central and peripheral stimulations of this system have been suggested to mediate obesity-related comorbidities, contributing to the development of the metabolic syndrome. 6, 8 Recently, we have demonstrated that over-activated CB 1 R mediates obesity-induced kidney injury, dysfunction, inflammation and fibrosis by compromising the function of renal proximal tubular cells (RPTCs). 9 RPTCs are metabolically active and reabsorb up to 80% of the solute and water passing through the nephron via specialized ATP-dependent membrane transporters. 10 To meet this high energy demand, RPTCs rely on mitochondrial oxidative phosphorylation (OXPHOS) to produce ATP. 11 Thus, an impairment in mitochondrial bioenergetics may result in renal dysfunction. Indeed, accumulating evidence links mitochondrial dysfunction to the development and progression of diseases such as acute kidney injury, diabetic nephropathy and chronic kidney disease. [11] [12] [13] [14] [15] [16] [17] This is further supported by our recent finding that RPTC dysfunction is accompanied by decreased utilization of fatty acids by mitochondria and impaired ATP production. Notably, these effects are rescued by a peripheral blockade of CB 1 R, 9 in agreement with reports by others who describe a role for the eCB/CB 1 R system in modulating different aspects of mitochondrial physiology. [18] [19] [20] [21] However, direct modulation of mitochondrial dynamics by eCBs has not yet been described. Here, we show that directly stimulating CB 1 R modulates mitochondrial dynamics and function in RPTCs. Specifically, activating CB 1 R promotes excessive mitochondrial fragmentation by regulating the phosphorylation of dynamin-related protein 1 (DRP1), leading to mitochondrial dysfunction in the kidney. Interestingly, an acute fatty acid overload also induces CB 1 R-dependent mitochondrial fragmentation in RPTCs, suggesting a role for the eCB system in mediating the mitochondrial damage associated with renal lipotoxicity.
| MATERIALS AND METHODS

| Animals and experimental protocol
All animal studies were approved by the Institutional Animal Care and Use Committee of the Hebrew University of Jerusalem (AAALAC accreditation #1285). Male, 8-10-week-old RPTC-CB 1 R -/mice 9, 22 and their wild-type (WT) littermate controls were used for the in vivo experiments. To activate CB 1 R, mice received a single intraperitoneal injection of 10 mg/kg AEA or arachidonyl-2 0 -chloroethylamide (ACEA) (90050 or 91054, respectively; Cayman Chemicals, Ann Arbor, Michigan). To test the effect of fatty acid flux-induced CB 1 R activation on the kidney, mice received a standard diet (STD) (14% fat, 24% protein, 62% carbohydrates; NIH-31 rodent diet) or a high-fat diet (HFD) (60% fat, 20% protein and 20% carbohydrates; Research Diet, D12492) for 7 days. Mice were euthanized by a cervical dislocation under anesthesia, and blood and kidneys were harvested for further analyses.
| Multi-parameter metabolic assessment
Mice were metabolically assessed using the Promethion High-Definition Behavioral Phenotyping System (Sable Instruments, Inc., Las Vegas, Nevada) as described previously. 9 2.3 | Cell culture WT or CB 1 R -/--HK-2 cells (human immortalized RPTCs) were maintained in a low glucose DMEM (01-050-1A; Biological Industries, Beit
Haemek, Israel) supplemented with 5% FCS, 100 mM glutamine, 100 mM Na-pyruvate and Pen/Strep (Thermo Fisher Scientific, UK).
Cells were cultured at 37 C in a humidified atmosphere of 5% CO 2 /95% air. To test the effect of CB 1 R activation, cells were seeded in 6-well plates (25 × 10 4 cells/well) for 24 hours. Then, growth medium was replaced with serum-free medium (SFM) for an additional 12 hours. On the morning of the experiment, the medium was replaced with fresh SFM containing either vehicle (EtOH), 5 μM AEA, 5 μM ACEA or 250 nM JZL195 for 6 hours. To mimic fatty conditions, cells were overloaded with a mixture of fatty acids containing 0.1 mM sodium Oleate (O7501; Sigma Aldrich, St. Louis, Missouri) and sodium Palmitate (P9767; Sigma Aldrich) in a ratio of 2:1 (O:P, respectively), dissolved in 11% free-fatty acid BSA solution (A7030; Sigma Aldrich).
At indicated time points, cells were harvested for further analyses as described below.
| Stable transfection of RPTCs for mitochondrial overexpression of GFP
HK-2 cells were transfected with pLYS1-FLAG-MitoGFP-HA (#50057; Addgene, Cambridge, Massachusetts), using Lipofecta-min3000 (L3000-001; Invitrogen, Thermo Fisher Scientific) according to the manufacturer's protocol. Transfected cells were selected with puromycin (1 μg/μL; P8833, Sigma Aldrich). Antibiotic-resistant cells were then sorted for high GFP expression using FACSAria II (Becton Dickinson, Franklin Lakes, New Jersey), were plated, and MitoGFP expression was validated using a IX-73 fluorescent microscope (OLYMPUS).
| Genetic deletion of CB 1 R in RPTCs
HK-2-MitoGFP cells were transfected with CRISPR-CAS9 vector containing a sgRNA sequence to target all human isoforms of CNR1 (GeneCopeia CS-HCP263432-CG01-01-B) using Lipofectamine3000 (L3000-001, Invitrogen), and were selected with hygromycin (200 μM; H3274, Sigma Aldrich). Antibiotic-resistant cells were then seeded in a single-cell density and were allowed to grow. Single-cell clones were analysed by DNA sequencing and mRNA analysis to confirm the deletion of CB 1 R ( Figure S1 ).
| Electron microscopy
Kidney slices (3 mm) were fixed overnight in 2% paraformaldehyde and 2.5% glutaraldeyde in 0.1 M cacodylate buffer (pH 7.4) at room temperature, and then washed four times in cacodylate buffer. Tissue slices were stained with 1% osmium tetroxide, 1.5% potassium ferricyanide in 0.1 M cacodylate buffer for 1 hour, were washed four times in cacodylate buffer and were dehydrated. Following dehydration, slices were infiltrated with increasing concentrations of Agar 100 resin in propylene oxide, consisting of 25%, 50%, 75% and 100% resin, for 16 hours each, and were then embedded in fresh resin and allowed to polymerize at 
| Extracellular flux analysis
The cellular oxygen consumption rate (OCR) was measured using a Seahorse XF24 Extracellular Flux Analyzer (Seahorse Bioscience, Agilent Technologies, Billerica, Massachusetts). Briefly, WT-MitoGFP and CB 1 R -/--MitoGFP HK-2 cells were seeded in an XF24 cell culture plate (25 × 10 3 cells/well) and were incubated overnight in a 37 C humidified incubator with 5% CO 2 . Then, vehicle, AEA or O:P was added to the cells in fresh SFM for the indicated times. Basal OCR was measured at the end of the incubation period. Data were calculated from five consecutive measurements, post instrument calibration.
2.8 | Total DNA extraction and mtDNA/nDNA measurement Cells were harvested using trypsin, and DNA was extracted with a DNeasy Blood & Tissue Kit (69056, QIAGEN) according to the manufacturer's protocol. Isolated DNA served as a template for a qPCR reaction using primer sets for β2-microglobulin (β2m) to amplify nuclear DNA (nDNA) and a D-loop region to amplify mitochondrial DNA (mtDNA). Primers are listed in Table S1.
| Quantification of mitochondrial morphology
Fluorescence images in .vsi format were processed in ImageJ software using the OlympusViewer Plugin, and were then subjected to analysis with the publicly available ImageJ macro for mitochondrial morphology, Mito-Morphology, designed by Ruben K. Dagda. 23 The macro returns the circularity value for each mitochondrion in the cell and the average circularity value of each measured cell. The average value AE SEM was plotted. The number of replicates is indicated in each figure legend. The perimeter of each mitochondria and the total mitochondrial area were also measured using the same macro. Interconnectivity was calculated as AVG area/perimeter ratio.
Electron microscope images in .tiff format were analysed using Adobe Photoshop C3S software. Images were analysed in RGB mode, and the measurement scale was set according to the image scale bar.
Each mitochondrion was marked using the magnetic laso tool, and measurements of area and perimeter were recorded. Circularity was calculated by the software as 4*π area perimeter 2, and the value of 1 represents a perfect circle. The length of mitochondria was measured by manually drawing a line along the mitochondrial major axis, using a ruler, and recording the value.
| Endocannabinoid measurements by LC-MS/MS
eCBs were extracted, purified and quantified in kidney and cells, as 3 | RESULTS
| Direct activation of CB 1 R impairs mitochondrial architecture of RPTCs
To evaluate the direct role of CB 1 R in regulating mitochondrial dynamics in RPTCs, we tested the acute effect of AEA (10 mg/kg, ip) or vehicle in RPTC-CB 1 R -/mice (lacking CB 1 R only in the RPTCs) 9 and in their WT littermate controls. Electron micrographs of kidney sections demonstrated extensive alterations in mitochondrial architecture, mainly in mitochondrial fragmentation, following AEA administration ( Figure 1A ). Whereas WT mice treated with vehicle showed many elongated mitochondria, the mice treated with AEA contained round and shorter mitochondria (quantified in Figure 1B ,C). The AEA-induced impairment of mitochondrial morphology was CB 1 R dependent, as RPTC-CB 1 R -/mice were protected from these morphological alterations ( Figure 1A -C). As AEA is known to be rapidly degraded in vivo, leading to the production of arachidonic acid (AA), which, in turn, may cause mitochondrial fission on its own, 24 we assessed the eCB "tone" in kidneys collected from mice 6 hours following an intraperitoneal injection of AEA. Renal AEA levels remained significantly high in comparison with Veh-treated controls, whereas no changes in the 2-AG and AA levels were found, highlighting the specificity of the effect documented by AEA ( Figure S2 ). Moreover, we repeated the above-mentioned experiment with the highly selective and stable CB 1 R agonist, ACEA, and found extensive mitochondrial fragmentation following its administration in vivo (10 mg/kg, ip) ( Figure S3 ), thus supporting the notion that the effect is CB 1 R mediated. As AEA was given systemically, we assumed that the CB 1 R-induced changes in mitochondrial architecture were not only restricted to the kidney, but could greatly affect the structure and activity of mitochondria elsewhere; indeed, an indirect assessment of mitochondrial activity in vivo revealed that acute AEA treatment resulted in decreased total oxygen consumption only in the WT animals ( Figure 1D ).
To further investigate the physiological role of the eCB/CB 1 R system in mitochondria of RPTCs, we established a cellular model in which CB 1 R was deleted from HK-2 cells, stably expressing mitochondrially targeted GFP, using the CRISPR-CAS genome editing technique ( Figure S1 ). In accordance with our in vivo findings, we found striking JZL195, a potent inhibitor of both fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL), the primary enzymes responsible for degrading AEA and 2-AG, respectively ( Figure S4 ), suggesting that mitochondrial dynamics in RPTCs are regulated by CB 1 R.
| Acute activation of CB 1 R in RPTCs impairs mitochondrial function and biogenesis
As mitochondrial shape is closely related to function, we next evaluated the functional consequence of CB 1 R activation on the mitochondria.
In vitro AEA treatment resulted in a significant reduction in the basal OCR, and substantially decreased ATP levels in WT-HK-2 cells (Figure 2A,B) . Similarly, AEA induced reduction in the NAD + /NADH ratio ( Figure 2C ), as well as a 15% increase in cellular lactate content ( Figure 2D ). All of the mitochondrial malfunctions induced by AEA were absent in CB 1 R -/--HK-2 cells. Next, we assessed the effect of AEA on mitochondrial biogenesis, and found that acute activation of CB 1 R in WT-HK-2, but not in CB 1 R -/--HK-2, cells resulted in a mild, yet significant, reduction in the mtDNA-to-nDNA ratio ( Figure 2E ). Likewise, the protein expression of two representative mitochondrial respiratory chain components, mtDNA-encoded cytochrome C oxidase I (MTCO1) and nDNA-encoded succinate dehydrogenase complex subunit A (SDHA) was downregulated following AEA exposure in WT-HK-2 cells ( Figure 2F ). As AEA has been shown to inhibit the proliferation of different cell lines, 25, 26 and to induce apoptosis in others, 27, 28 we wanted to exclude the possibility that the observed mitochondrial changes resulted from the deleterious effects of AEA on cell viability. Therefore, we performed CFSE staining, followed by FACS analysis, and revealed that AEA did not affect cell proliferation ( Figure 2G ). Moreover, no increase in the number of early or late apoptotic cells following AEA treatment was documented ( Figure 2H ). Taken together, our findings suggest that CB 1 R-mediated mitochondrial fragmentation is followed by impaired mitochondrial function and reduced biogenesis, without compromising cell viability in the observed time frame.
| RPTC-CB 1 R induces DRP1-mediated mitochondrial fission
To decipher the underlying molecular mechanism involved in CB 1 Rinduced mitochondrial fragmentation, we assessed the contribution of DRP1, a fundamental component of the fission machinery, to this phenomenon. At the mRNA level, DRP1 was slightly upregulated by AEA in WT-HK-2 cells ( Figure 3A ). On the other hand, a reduction in its phosphorylation on S637 was induced by AEA treatment in WTbut not in CB 1 R -/--HK-2 cells ( Figure 3B,C) . Interestingly, the basal ratio between the S637-phosphorylated and total DRP1 in CB 1 R -/--HK-2 cells was higher than in the WT-HK-2 cells ( Figure 3B ,C), concurrent with their hyper-fused mitochondrial network ( Figure 1E-H) .
ACEA and JZL195 also reduced this ratio in a way similar to AEA ( Figure S4D ,E). When phosphorylated on S637, DRP1 is retained in the cytoplasm and, upon de-phosphorylation, it is translocated to the mitochondria and induces fission. 29, 30 Indeed, in a cellular fractionation analysis, AEA treatment led to decreased recovery of both S637-phosphorylated DRP1 and total DRP1 from the cytoplasm of RPTCs, and increased the recovery of total DRP1 from the mitochondrial fraction compared with vehicle-treated cells ( Figure 3D ). The fractionation fidelity and efficiency were controlled using anti-GFP, which could be recovered only from the mitochondria. Furthermore, by using immune-fluorescence, we found that DRP1 was distributed throughout 
| CB 1 R-mediated mitochondrial fragmentation is cAMP-dependent
To further corroborate the PKA signaling pathway in this process, we treated both cell lines with Forskolin, a potent inducer of cAMP generation. As expected, this treatment resulted in reduced mitochondrial circularity in both WT-HK-2 and CB 1 R -/--HK-2 cells ( Figure 4A,B) , an Acute activation of CB 1 R in HK-2 cells impairs mitochondrial function and biogenesis. WT-HK-2 or CB 1 R -/--HK-2 cells were treated with either vehicle (Veh) or 5 μM AEA for 6 hours and were then analysed for mitochondrial function. A, Reduced oxygen consumption rate (OCR) measured using the Seahorse XF analyzer, B, reduced ATP levels, and C, reduced NAD + /NADH ratio, as well as D, elevated cellular lactate levels, were found in WT-HK-2 cells treated with AEA (5 μM). Data represent the mean AE SEM of at least six replicates from three independent experiments. E, The ratio between mitochondrial and nuclear DNA. F, FACS analysis for MTCO-1 and SDHA, demonstrating reduced biogenesis following treatment of wild-type cells with AEA. G, H, WT-HK-2 cells, exposed to Veh or 5 μM AEA, were analysed by flow cytometry for proliferation (G) with CFSE staining after 24 hours of treatment or for apoptosis (H) with Annexin V and Propidium Iodide at the indicated time points. Data represent one experiment out of three performed (in triplicate). *P < 0.05 relative to Veh-treated HK-2 of the same cell line. # P < 0.05 relative to the same treated group in WT-HK-2 cells effect that could be attributed to increased S637 phosphorylation of DRP1 ( Figure 4C,D) . The decreased circularity was reversed by AEA treatment in WT-HK-2 cells only, but not in HK-2 cells lacking the CB 1 R (Figure 4A,B 
| Deletion of CB 1 R ameliorates fatty acidinduced mitochondrial fragmentation in RPTCs
High-fat diet (HFD) feeding was shown to induce vast changes in mitochondrial architecture in the kidney, leading to proximal tubular injury and glomerulopathy. 36 We recently reported that CB 1 R blockade protects against HFD-induced reduction in mitochondrial fatty acid β-oxidation and ATP production. 9 This, together with the current data, encouraged us to explore the possibility that the eCB/CB 1 R system is also involved in HFD-mediated changes in mitochondrial architecture. Specifically, we evaluated the effect of an acute fatty acid overload on mitochondrial dynamics in RPTCs both in vivo and in vitro. To that end, we fed RPTC-CB 1 R -/mice and their WT littermate controls with either STD or HFD for a short-term period, and followed mitochondrial shape and fat accumulation in the RPTCs.
Interestingly, HFD-fed WT animals exhibited an extensive impairment of mitochondrial morphology in RPTCs, while RPTC-CB 1 R -/mice were almost completely protected from these alterations ( Figure 5A ).
These alterations included increased mitochondrial circularity ( Figure 5B ) and reduced mitochondrial length ( Figure 5C ), as well as increased accumulation of fat droplets within RPTCs (Figure 5A , yellow arrows). As expected, both mouse strains gained a similar body weight (data not shown), as well as increased whole-body oxygen consumption and total fat oxidation ( Figure 5D,E Figure 5M,N) , which are often associated with mitochondrial dysfunction, 37,38 supporting a common mechanism that mediates mitochondrial damage in both experimental models.
| DISSCUSSION
The ability of the eCB/CB 1 R system to regulate energy balance and metabolism is well established, including its effects on appetite 39, 40 and energy expenditure. 41 These effects are not only limited to central regulation, because the eCB system, specifically via the CB 1 R, controls cellular metabolism in peripheral organs also, including the liver, adipose tissue and kidney. [42] [43] [44] [45] [46] Whereas several lines of investigation suggest that the eCB/CB 1 R system regulates bioenergetics by directly regulating mitochondrial function (reviewed in Reference 19) , no evidence implicating mitochondrial dynamics in this phenomenon has yet been reported. Here, we documented, for the first time, the involvement of CB 1 R in regulating mitochondrial morphology and assessed its relevance to renal lipotoxicity.
Previous reports clearly link altered metabolic flux with mitochondrial shape and function (reviewed in Reference 47). Specifically, metabolic insults, such as elevated levels of glucose 48, 49 or fatty acids, 50 result in mitochondrial fragmentation and dysfunction. As CB 1 R activation recapitulates the conditions of excess nutrients, it was very exciting to discover that AEA, its stable analog, ACEA, or increased eCB "tone" induces excessive mitochondrial fragmentation in RPTCs.
This notion is further supported by our findings that short-term HFD feeding in vivo and acute exposure to fatty acids in vitro result in mitochondrial fragmentation, mediated also via the CB 1 R. Similarly, long-term HFD feeding has been shown to induce mitochondrial fragmentation in the kidney, 36 and treating obese mice with SS-31, which protects cristae structure, preserves mitochondrial architecture and restores normal mitochondrial function, 36 emphasizing the tight link between architecture and function. Likewise, our findings suggest that activating the eCB system via CB 1 R may link fatty acid flux with mitochondrial fragmentation. These findings are of great importance, considering the well-documented contribution of mitochondrial dysfunction to the development of kidney injury, [15] [16] [17] 51, 52 making CB 1 R a compelling target for treating lipotoxicity-related kidney damage. Indeed, our recent work supports this notion as peripheral CB 1 R blockade, as well as its specific genetic deletion from RPTCs, ameliorates obesity-induced kidney dysfunction, inflammation and tubulointerstitial fibrosis by preventing lipid accumulation and subsequent lipotoxicity, which is associated with abnormal mitochondrial function of RPTCs. 9 The current work further highlights the contribution of CB 1 R-induced mitochondrial fragmentation to such cellular damage.
These findings could generally be associated with regulating energy utilization because the kidneys are second only to the heart in mitochondrial abundance and oxygen consumption, 53 and because the RPTCs constitute approximately half of the kidney mass and use the majority of oxygen consumed by the organ. 54 A link between mitochondrial morphology and bioenergetics was first reported decades ago, 55 with a substantial amount of supporting data accumulating ever since. The relationship between the two mitochondrial features is reciprocal, as evident from studies showing that manipulation of mitochondrial dynamics led to deficiencies in mitochondrial respiration and ATP depletion. 56 In contrast, a few studies reported that inhibiting complex I, or complementing it genetically, can affect mitochondrial fragmentation. 1, 57 In accordance with recent reports demonstrating that AEA induces reduced OXPHOS and ATP production, 58, 59 we documented here reduced OCR, as well as reduced ATP levels and the NAD + /NADH ratio in WT-but not in CB 1 R -/--HK-2 cells treated with AEA, suggesting a functional decline in mitochondrial respiration following CB 1 R activation.
Previous studies have linked activated CB 1 R with decreased mitochondrial biogenesis in other tissues. 21 64 As AEA also activates CB 2 R and interacts with other membrane receptors, ion channels and effector proteins, 65 it is possible that some of the AEA-induced changes are mediated via other receptors. In fact, there is evidence that AEA also exerts some of its actions in CB 1 R null mice. 65 Nevertheless, as most of the effects of AEA observed here were negated in RPTC-CB 1 R -/mice and in CB 1 R -/--HK-2 cells, as well as the fact that both ACEA-and JZL195-induced eCB production resulted in a similar degree of mitochondrial fragmentation in RPTCs, off-target effects are less likely to mediate the entire phenomenon described here. Suggested mechanism linking CB 1 R and mitochondrial dynamics. Left panel describes normal conditions in which PKA is active, thereby phosphorylating DRP1 on S637. This inhibitory phosphorylation retains DRP1 in the cytoplasm and fission is limited. Right panel describes either a direct activation of CB 1 R with AEA or a fatty acid flux-induced indirect activation of CB 1 R that inhibits PKA, leading to decreased phosphorylation of S637, which allows DRP1 to target mitochondria and induce fission. PKA inhibition subsequently activates ERK 1/2 , which phosphorylates DRP1 on S616, further promoting fission. Excessive mitochondrial fragmentation under these conditions is followed by a functional decline of mitochondria of both S616-phosphorylated and total-DRP1 following CB 1 R stimulation further supports enhanced fission, as such peri-nuclear clustering of fragmented mitochondria following the induction of fission has been reported previously. 68 After CB 1 R was identified as a classic plasma membrane receptor, the effects of cannabinoids on mitochondrial function were thought to be either the indirect result of stimulating CB 1 Rs present on the plasma membrane or the result of unspecific changes in the mitochondrial membranes by these lipid ligands. 69 Conversely, consistent evidence shows that mitochondria contain G proteins and their downstream effectors. In fact, 30% of neuronal mitochondria carry CB 1 Rs (mtCB 1 R), and both Δ 9 -THC and eCBs suppress electron transport complex I activity and respiration in isolated mitochondria, probably by reducing cAMP levels and PKA activity. 70 Since this initial discovery, others have suggested the presence of CB 1 Rs in the mitochondria of different organs. 71, 72 Whether cannabinoids also modulate mitochondrial dynamics via a direct effect on mtCB 1 R in RPTCs remains to be determined, and we are currently conducting studies to elucidate this phenomenon.
In conclusion, our data describe a novel role for CB 1 R in modulating mitochondrial physiology by regulating the phosphorylation levels of DRP1 ( Figure 6 ). We suggest that a direct CB 1 R activation, or a fatty environment, indirectly, may inhibit the activity of PKA, thereby reducing the phosphorylation of DRP1 on S637. In addition, CB 1 R stimulation led to increased phosphorylation of ERK 1/2 which, in turn, may contribute to the enhanced phosphorylation of DRP1 on S616.
Consequently, increased mitochondrial fission occurs, leading to deterioration in mitochondrial function. This, in turn, may lead to RPTC dysfunction, documented in obesity and other metabolic diseases associated with kidney damage.
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